Respiratory Research

Associations between resources and practices of ILD centers and outcomes in patients with idiopathic pulmonary fibrosis: data from the IPF-PRO Registry.  23. 2022

Comparative transcriptomics in human COPD reveals dysregulated genes uniquely expressed in ferrets.  23. 2022

Increased chest CT derived bone and muscle measures capture markers of improved morbidity and mortality in COPD.  23. 2022

Association of plasma mitochondrial DNA with COPD severity and progression in the SPIROMICS cohort.  22. 2021

Hospitalizations in patients with idiopathic pulmonary fibrosis.  22. 2021

InforMing the PAthway of COPD Treatment (IMPACT) trial: fibrinogen levels predict risk of moderate or severe exacerbations.  22. 2021

Inhaled high molecular weight hyaluronan ameliorates respiratory failure in acute COPD exacerbation: a pilot study.  22. 2021

MicroRNA 219-5p inhibits alveolarization by reducing platelet derived growth factor receptor-alpha.  22. 2021

Mucus plugging on computed tomography and chronic bronchitis in chronic obstructive pulmonary disease.  22. 2021

Airway nitrite is increased in extremely preterm infants with bronchopulmonary dysplasia.  21. 2020

Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol and umeclidinium/vilanterol in patients with COPD: Results on cardiovascular safety from the IMPACT trial.  21. 2020

Differences in airway microbiome and metabolome of single lung transplant recipients.  21. 2020

Heme metabolism genes Downregulated in COPD Cachexia.  21. 2020

Evaluation of secondhand smoke effects on CFTR function in vivo.  21. 2020

The matrikine acetyl-proline-glycine-proline and clinical features of COPD: Findings from SPIROMICS.  20. 2019

Peripheral blood proteomic profiling of idiopathic pulmonary fibrosis biomarkers in the multicentre IPF-PRO Registry.  20. 2019

Predictors of death or lung transplant after a diagnosis of idiopathic pulmonary fibrosis: Insights from the IPF-PRO Registry.  20. 2019

It's more than low BMI: Prevalence of cachexia and associated mortality in COPD.  20. 2019

Centrilobular emphysema and coronary artery calcification: Mediation analysis in the SPIROMICS cohort.  19. 2018

Pectoralis muscle area and mortality in smokers without airflow obstruction.  19. 2018

Association of thrombocytosis with COPD morbidity: The SPIROMICS and COPDGene cohorts.  19. 2018

Roflumilast reverses CFTR-mediated ion transport dysfunction in cigarette smoke-exposed mice.  18. 2017

Effect of beta-blockers on exacerbation rate and lung function in chronic obstructive pulmonary disease (COPD).  18. 2017

GDF-15 plasma levels in chronic obstructive pulmonary disease are associated with subclinical coronary artery disease.  18. 2017

Validated and longitudinally stable asthma phenotypes based on cluster analysis of the ADEPT study.  17. 2016

Utilization due to chronic obstructive pulmonary disease and its predictors: A study using the U.S. National Emergency Department Sample (NEDS).  17. 2016

Longitudinal stability of asthma characteristics and biomarkers from the Airways Disease Endotyping for Personalized Therapeutics (ADEPT) study.  17:1-12. 2016

Asthma characteristics and biomarkers from the Airways Disease Endotyping for Personalized Therapeutics (ADEPT) longitudinal profiling study.  16. 2015

Roflumilast partially reverses smoke-induced mucociliary dysfunction.  16. 2015

Fluticasone propionate/salmeterol 250/50 μg versus salmeterol 50 μg after chronic obstructive pulmonary disease exacerbation.  15. 2014

Genetic susceptibility for chronic bronchitis in chronic obstructive pulmonary disease.  15. 2014

DNAH5 is associated with total lung capacity in chronic obstructive pulmonary disease.  15. 2014

Airway wall thickness is increased in COPD patients with bronchodilator responsiveness.  15. 2014

Epidemiology, genetics, and subtyping of preserved ratio impaired spirometry (PRISm) in COPDGene.  15. 2014

Clinical and computed tomographic predictors of chronic bronchitis in COPD: A cross sectional analysis of the COPDGene study.  15. 2014

Acquired defects in CFTR-dependent β-adrenergic sweat secretion in chronic obstructive pulmonary disease.  15. 2014

Impact of heterozygote CFTR Mutations in COPD patients with Chronic Bronchitis.  15. 2014

Suspected acute exacerbation of idiopathic pulmonary fibrosis as an outcome measure in clinical trials.  14. 2013

Exploring factors influencing asthma control and asthma-specific health-related quality of life among children.  14. 2013

Pre- and post-bronchodilator lung function as predictors of mortality in the Lung Health Study.  12. 2011

The clinical features of the overlap between COPD and asthma.  12. 2011

N-α-PGP and PGP, potential biomarkers and therapeutic targets for COPD.  10. 2009

Longitudinal association of body mass index with lung function: The CARDIA Study.  9. 2008

Inhaled tolafentrine reverses pulmonary vascular remodeling via inhibition of smooth muscle cell migration.  6. 2005

Estimation of airway obstruction using oximeter plethysmograph waveform data.  6. 2005